Dr. Stephen C. Yang
Professor, Surgery and Oncology
Duke University - 1980
Medical College of Virginia - 1984
University of Texas Health Science Center
University of Texas M.D. Anderson Cancer Center
Overview and Educational Background
Dr. Stephen C. Yang is currently an Associate Professor of Surgery and Oncology at the Johns Hopkins University School of Medicine. He began his medical career by earning his undergraduate degree in Chemistry from Duke University in 1980. He then went on to attend the Medical College of Virginia and completed his surgical residency at the University of Texas Health Science Center in Houston. Dr. Yang fulfilled his Fellowship at the University of Texas M.D. Anderson Cancer Center. Finally, he went on to complete a cardiothoracic fellowship at the Medical College of Virginia.
Dr. Yang is board certified with the American Board of Surgery, the American Board of Thoracic Surgery, the Faculty of the American College of Surgeons (F.A.C.S.) as well as the Faculty of the College of Chest Physicians (F.C.C.S.). He is also a part of the International Association for Minimally Invasive Cardiothoracic Surgery.
Aside from his position as an Associate Professor of Surgery, Dr. Yang also holds the title of Surgical Director of the Lung Transplantation Program, Surgical Director of the Thoracic Oncology Program and Chief of the Division of Thoracic Surgery at Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center.
Dr. Yang has completed an extensive amount of research into a number of different interests. He has studied the development of molecular markers for the early diagnosis of lung cancer, the molecular biology of mesothelioma, the detection of telomerase activity to detect the presence of lung cancer and finally, the development of molecular markers for early diagnosis of recurrent lung cancer after surgical resection.
Dr. Yang's clinical work, similar to his research, focuses on a number of lung and chest related areas. These interests include: mesothelioma (including peritoneal mesothelioma and pericardial mesothelioma), the surgery, early diagnosis (stage 1 and stage 2) and detection of lung cancer, mediastinal masses, lung diseases such as fibrosis and emphysema, CT scanning for early diagnosis of tobacco related diseases and lung transplantation in both children and adults. From 1997-1999 Dr. Yang was named the Andrew G. Morrow Research Scholar.
Dr. Yang has also spent time clinically studying the surgery, early diagnosis and detection of esophageal cancer as well as neoadjuvant therapy, a preoperative multi-modal treatment combining chemo and radiation therapy. His technological clinical interests include video-assisted thoracic surgery/thoracoscopy, robotic assisted thoracic surgery and lung volume reduction surgery for emphysema.
A number of scholarly articles have been authored or co-authored by Dr. Yang. In March of 2008 his article, "DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer," was published in The New England Journal of Medicine. Another article, "p53 Mutations and Survival in Stage I Non-Small-Cell Lung Cancer: Results of a Prospective Study," was published in the Journal of the National Cancer Institute in 2003.Sources
Johns Hopkins Physician Profile